Seeking Alpha
 

China Biologic Products, Inc. (CBPO)

- NASDAQ
  • Fri, Jun. 26, 5:37 PM
    | 16 Comments
  • Mon, Jun. 8, 12:49 PM
    | 26 Comments
  • Jul. 8, 2014, 12:46 PM
    | Comment!
  • Jun. 18, 2014, 12:45 PM
    | 5 Comments
  • Feb. 19, 2014, 12:45 PM
    | 1 Comment
  • Jun. 7, 2013, 12:45 PM
    Midday top 10 gainers: OSH +23%. WSBF +19%. OPTT +17%. CSFS +14%. BDBD +13%. JKS +11%. ROSG +11%. THO +10%. ECTY +10%. KFS +9%.
    Midday top 10 Losers: FSGI -56%. TIVO -17%. USM -17%. IRM -16%. ZQK -12%. JRCC -11%. LQDT -11%. AFFY -10%. CBPO -10%. TRUE -8%.
    | Comment!
  • Jan. 2, 2013, 2:51 PM
    China Biologic Products (CBPO -4.6%) slips after announcing earlier today that construction of a new production facility at its Guizhou Taibang subsidiary could be delayed due to slower-than-expected government approval of land use rights. The Company says it's working closely with local authorities to secure approval as soon as possible and will provide an update as soon as possible. CBPO had planned to commence work on the project in late 2012, with completion by mid-2014.
    | Comment!
  • Jul. 15, 2011, 4:04 PM
    China Biologic Products (CBPO -6.5%) takes a hit today after receiving notification from the Guizhou Provincial Health Department that the government has suspended the company's blood collection activities in the province. The suspension affects four of six collection sites it runs, and the impact upon current business operations could be significant.
    | Comment!
Visit Seeking Alpha's
CBPO vs. ETF Alternatives
Company Description
China Biologic Products Inc is a biopharmaceutical company that is engaged in the research, development, manufacturing and sales of plasma-based pharmaceutical products to hospitals and inoculation centers directly or through distributors in China.
Sector: Healthcare
Industry: Biotechnology
Country: China